Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes

NCT04373967 · clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
424
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.